| Prev Close: | 0.23 |
|---|---|
| Open: | 0.22 |
| Bid: | 0.20 |
| Ask: | 0.22 |
| 1y Target Est: | N/A |
| Beta: | N/A |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | 0.20 - 0.22 |
|---|---|
| 52wk Range: | 0.19 - 0.64 |
| Volume: | 21,777 |
| Avg Vol (3m): | 20,974 |
| Market Cap: | 8.46M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Lorus Therapeutics Signs Research and License Option Agreement with ElancoMarketwired(Wed Apr 17)
- Lorus Therapeutics Signs Research and License Option Agreement With ElancoGlobeNewswire(Wed Apr 17)
- Lorus Therapeutics Signs Research and License Option Agreement with ElancoMarketwired(Wed Apr 17)
- Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013Marketwired(Fri Apr 12)
- Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013Marketwired(Fri Apr 12)
- Lorus Therapeutics Announces Presentation of Biomarker Data for LOR-253 at 2013 AACR Annual MeetingGlobeNewswire(Wed Apr 10)
- Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253Marketwired(Tue Mar 5)
- Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253Marketwired(Tue Mar 5)
- Ubika Research’s Daily Canadian Box Score: Top Junior Energy (TSX VENTURE: EM) Stock Gained 29%Accesswire(Tue Feb 19)
- Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual MeetingMarketwired(Tue Feb 12)
- Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual MeetingMarketwired(Tue Feb 12)
- Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17EMarketwired(Tue Jan 22)
- Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17EMarketwired(Tue Jan 22)
- Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2013Marketwired(Mon Jan 14)
- Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2013Marketwired(Mon Jan 14)
Press Releases
- Lorus Therapeutics Signs Research and License Option Agreement with ElancoMarketwired(Wed Apr 17)
- Ubika Research’s Daily Canadian Box Score: Top Junior Energy (TSX VENTURE: EM) Stock Gained 29%Accesswire(Tue Feb 19)
- Ubika Research’s Daily Canadian Box Score: Top Junior Industrials (CNSX: CFQ) Stock Gained 50%Accesswire(Mon Jan 7)
Must Read
- Oil falls below $94 as China manufacturing contractsThe Canadian Press(Wed May 22)
- These beaches have gone to the dogs; lucky pooches lap up the shoreline where they run freeThe Canadian Press(Wed May 22)
- HP's 2nd-qtr report shows signs of further decay but offers hope of recovery; stock soarsThe Canadian Press(Wed May 22)
- HP raises 2013 outlook as Whitman's plan takes holdReuters(Wed May 22)
- Clearwire, shareholders brace for fight over Sprint bidReuters(Wed May 22)